238 related articles for article (PubMed ID: 26119422)
1. 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function.
Besa C; Bane O; Jajamovich G; Marchione J; Taouli B
Magn Reson Imaging; 2015 Nov; 33(9):1075-1082. PubMed ID: 26119422
[TBL] [Abstract][Full Text] [Related]
2. Staging liver fibrosis in chronic hepatitis B with T
Yang L; Ding Y; Rao S; Chen C; Wu L; Sheng R; Fu C; Zeng M
J Magn Reson Imaging; 2017 Apr; 45(4):1186-1194. PubMed ID: 27563840
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
Khouri Chalouhi C; Vernuccio F; Rini F; Duca P; Tuscano B; Brancatelli G; Vanzulli A
Eur Radiol; 2019 Jun; 29(6):3090-3099. PubMed ID: 30547205
[TBL] [Abstract][Full Text] [Related]
4. T1 mapping for liver function evaluation in gadoxetic acid-enhanced MR imaging: comparison of look-locker inversion recovery and B
Kim JE; Kim HO; Bae K; Choi DS; Nickel D
Eur Radiol; 2019 Jul; 29(7):3584-3594. PubMed ID: 30903328
[TBL] [Abstract][Full Text] [Related]
5. Biliary tract enhancement in gadoxetic acid-enhanced MRI correlates with liver function biomarkers.
Noda Y; Goshima S; Kajita K; Kawada H; Kawai N; Koyasu H; Matsuo M; Bae KT
Eur J Radiol; 2016 Nov; 85(11):2001-2007. PubMed ID: 27776652
[TBL] [Abstract][Full Text] [Related]
6. Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla.
Verloh N; Haimerl M; Rennert J; Müller-Wille R; Nießen C; Kirchner G; Scherer MN; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
Eur J Radiol; 2013 Oct; 82(10):1710-5. PubMed ID: 23806531
[TBL] [Abstract][Full Text] [Related]
7. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic.
Zhou ZP; Long LL; Qiu WJ; Cheng G; Huang LJ; Yang TF; Huang ZK
Abdom Radiol (NY); 2017 Sep; 42(9):2272-2278. PubMed ID: 28396918
[TBL] [Abstract][Full Text] [Related]
9. Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging.
Ding Y; Rao SX; Zhu T; Chen CZ; Li RC; Zeng MS
Clin Radiol; 2015 Oct; 70(10):1096-103. PubMed ID: 26164421
[TBL] [Abstract][Full Text] [Related]
10. Performance of native and gadoxetate-enhanced liver and spleen T
Altinmakas E; Bane O; Hectors SJ; Issa R; Carbonell G; Abboud G; Schiano TD; Thung S; Fischman A; Kelly MD; Friedman SL; Kennedy P; Taouli B
Abdom Radiol (NY); 2022 Nov; 47(11):3758-3769. PubMed ID: 36085378
[TBL] [Abstract][Full Text] [Related]
11. T
Yang L; Ding Y; Rao S; Chen C; Zeng M
J Magn Reson Imaging; 2021 Mar; 53(3):896-902. PubMed ID: 32979019
[TBL] [Abstract][Full Text] [Related]
12. T2
Yoo H; Lee JM; Yoon JH; Kang HJ; Lee SM; Yang HK; Han JK
Korean J Radiol; 2017; 18(4):682-690. PubMed ID: 28670163
[TBL] [Abstract][Full Text] [Related]
13. Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla.
Zhou ZP; Long LL; Qiu WJ; Cheng G; Huang LJ; Yang TF; Huang ZK
BMC Med Imaging; 2017 Mar; 17(1):20. PubMed ID: 28249571
[TBL] [Abstract][Full Text] [Related]
14. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
Ding Y; Rao SX; Chen C; Li R; Zeng MS
Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study.
Li J; Cao B; Bi X; Chen W; Wang L; Du Z; Zhang X; Yu X
Radiol Med; 2021 Sep; 126(9):1149-1158. PubMed ID: 34105102
[TBL] [Abstract][Full Text] [Related]
16. Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase.
Ippolito D; Pecorelli A; Famularo S; Bernasconi D; Orsini EB; Giani A; Romano F; Talei Franzesi C; Sironi S
Abdom Radiol (NY); 2019 Apr; 44(4):1340-1349. PubMed ID: 30411177
[TBL] [Abstract][Full Text] [Related]
17. High spatial resolution, respiratory-gated, t1-weighted magnetic resonance imaging of the liver and the biliary tract during the hepatobiliary phase of gadoxetic Acid-enhanced magnetic resonance imaging.
Lee ES; Lee JM; Yu MH; Shin CI; Woo HS; Joo I; Stemmer A; Han JK; Choi BI
J Comput Assist Tomogr; 2014; 38(3):360-6. PubMed ID: 24681858
[TBL] [Abstract][Full Text] [Related]
18. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index.
Motosugi U; Ichikawa T; Oguri M; Sano K; Sou H; Muhi A; Matsuda M; Fujii H; Enomoto N; Araki T
Magn Reson Imaging; 2011 Oct; 29(8):1047-52. PubMed ID: 21775085
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of gadoxetic acid-enhanced MRI for the differential diagnosis of focal liver lesions: Comparison between estimated intralesional gadoxetic acid retention by T1 mapping and conventional processing methods.
Morisaka H; Seno D; Sakurai Y; Sano K; Akamine Y; Ichikawa T; Okada Y
Eur J Radiol; 2021 May; 138():109620. PubMed ID: 33713905
[TBL] [Abstract][Full Text] [Related]
20. Hepatobiliary phase imaging in cirrhotic patients using compressed sensing and controlled aliasing in parallel imaging results in higher acceleration.
Yoon S; Shim YS; Park SH; Sung J; Nickel MD; Kim YJ; Lee HY; Kim HJ
Eur Radiol; 2024 Apr; 34(4):2233-2243. PubMed ID: 37731096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
